Atria Wealth Solutions, Inc. Collegium Pharmaceutical, Inc Transaction History

Atria Wealth Solutions, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 22, 2023	BUY	$23.0 - $29.88 $385,917 - $501,356	16,779 New	16,779 $402,000
Q1 2023 Jun 14, 2023	BUY	$23.0 - $29.88 $37,789 - $49,092	1,643 Added 9.79%	18,422 $441,000
Q1 2023 May 10, 2023	SELL	$23.0 - $29.88 $37,789 - $49,092	-1,643 Reduced 8.92%	16,779 $402,000
Q4 2022 Aug 30, 2023	BUY	$16.14 - $23.55 $297,331 - $433,838	18,422 New	18,422 $427,000
Q4 2022 Feb 13, 2023	BUY	$16.14 - $23.55 $297,331 - $433,838	18,422 New	18,422 $427,000

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.